Genentech Invests More Than $125 Million To Expand Its Hillsboro, Oregon, Research Facility
03/26/2015
“This investment in our sterile production operations will result in the addition of up to 100 new skilled manufacturing jobs in the greater Portland area over the next five years, potentially bringing the total number of Genentech jobs in Oregon to over 500,” said Larry Sanders, General Manager and Vice President, Hillsboro Technical Operations.
“This announcement is another indicator that this is an exciting time in Oregon’s history,” said Governor Kate Brown. “Genentech’s investment in its Hillsboro campus and Oregon’s robust workforce underscore that Oregon is a great place for all businesses to build their future and for the biotech sector to grow.”
Genentech opened operations in Hillsboro in April 2010. The site is home to a state-of-the-art fill/finish facility and warehousing and distribution center. Genentech's product pipeline is among the strongest in the biotechnology and pharmaceutical industries, and demand for its marketed products continues to grow. The expansion of operations at the Hillsboro site is part of the company’s strategy to increase manufacturing capacity to meet that demand.
“Genentech’s plan to expand its Hillsboro facility represents an important milestone in the industry’s growth trajectory in Oregon. Combined with other recent achievements like the historic Knight Cancer Challenge, Oregon is positioned to significantly expand our life sciences manufacturing footprint,” said Dennis McNannay, Executive Director of the Oregon Bioscience Association.
Most Read
-
-
The New Normal in the Automotive Supply Chain
2020 Auto/Aero Site Guide
-
Why are Foreign Trade Zones Making a Comeback?
Q3 2020
-
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Q1 2020
-
Infrastructure Investment as an Economic Stimulus Tool
Q3 2020
-
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Q3 2019
-
The Next Recovery: Regional Leaders & Laggards
Q3 2020